Supplemental material
Research Paper
ESCRT-mediated phagophore sealing during mitophagy
, , 
, , , , , , , , , & show all
Michael J. MunsonCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Medicine, Institute of Basic Medical Sciences, Oslo, Norwayhttps://orcid.org/0000-0001-9927-8157View further author information
https://orcid.org/0000-0001-9927-8157View further author information, , , Kia-Wee TanCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norwayhttps://orcid.org/0000-0001-7527-9905View further author information
https://orcid.org/0000-0001-7527-9905View further author information, Vigdis SørensenCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norwayhttps://orcid.org/0000-0002-1694-890XView further author information
https://orcid.org/0000-0002-1694-890XView further author information, Eva Maria WenzelCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norwayhttps://orcid.org/0000-0002-5561-3344View further author information
https://orcid.org/0000-0002-5561-3344View further author information, , , Anne SimonsenCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Medicine, Institute of Basic Medical Sciences, Oslo, Norwayhttps://orcid.org/0000-0003-4711-7057View further author information
https://orcid.org/0000-0003-4711-7057View further author information, Camilla RaiborgCentre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Montebello, Norway;Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Norwayhttps://orcid.org/0000-0002-5406-5403View further author information
https://orcid.org/0000-0002-5406-5403View further author information & show all